Annual Total Long Term Liabilities
$60.56 M
-$6.72 M-9.99%
31 December 2023
Summary:
Lyell Immunopharma annual total long term liabilities is currently $60.56 million, with the most recent change of -$6.72 million (-9.99%) on 31 December 2023. During the last 3 years, it has fallen by -$80.00 million (-56.92%). LYEL annual total long term liabilities is now -59.86% below its all-time high of $150.88 million, reached on 31 December 2021.LYEL Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$55.01 M
-$1.76 M-3.09%
30 September 2024
Summary:
Lyell Immunopharma quarterly total long term liabilities is currently $55.01 million, with the most recent change of -$1.76 million (-3.09%) on 30 September 2024. Over the past year, it has dropped by -$7.35 million (-11.78%). LYEL quarterly long term liabilities is now -63.95% below its all-time high of $152.58 million, reached on 30 September 2021.LYEL Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LYEL Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -10.0% | -11.8% |
| 3 y3 years | -56.9% | -64.0% |
| 5 y5 years | - | - |
LYEL Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -59.9% | at low | -64.0% | at low |
| 5 y | 5 years | -59.9% | at low | -64.0% | at low |
| alltime | all time | -59.9% | at low | -64.0% | at low |
Lyell Immunopharma Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $55.01 M(-3.1%) |
| June 2024 | - | $56.76 M(-3.3%) |
| Mar 2024 | - | $58.71 M(-3.1%) |
| Dec 2023 | $60.56 M(-10.0%) | $60.56 M(-2.9%) |
| Sept 2023 | - | $62.35 M(-2.7%) |
| June 2023 | - | $64.11 M(-2.6%) |
| Mar 2023 | - | $65.83 M(-2.2%) |
| Dec 2022 | $67.28 M | $67.28 M(-36.5%) |
| Sept 2022 | - | $106.03 M(+2.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $103.34 M(-31.0%) |
| Mar 2022 | - | $149.80 M(-0.7%) |
| Dec 2021 | $150.88 M(+7.3%) | $150.88 M(-1.1%) |
| Sept 2021 | - | $152.58 M(+5.8%) |
| June 2021 | - | $144.25 M(+0.6%) |
| Mar 2021 | - | $143.46 M(+2.1%) |
| Dec 2020 | $140.56 M(+12.0%) | - |
| Dec 2020 | - | $140.56 M |
| Dec 2019 | $125.53 M | - |
FAQ
- What is Lyell Immunopharma annual total long term liabilities?
- What is the all time high annual total long term liabilities for Lyell Immunopharma?
- What is Lyell Immunopharma annual total long term liabilities year-on-year change?
- What is Lyell Immunopharma quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Lyell Immunopharma?
- What is Lyell Immunopharma quarterly long term liabilities year-on-year change?
What is Lyell Immunopharma annual total long term liabilities?
The current annual total long term liabilities of LYEL is $60.56 M
What is the all time high annual total long term liabilities for Lyell Immunopharma?
Lyell Immunopharma all-time high annual total long term liabilities is $150.88 M
What is Lyell Immunopharma annual total long term liabilities year-on-year change?
Over the past year, LYEL annual total long term liabilities has changed by -$6.72 M (-9.99%)
What is Lyell Immunopharma quarterly total long term liabilities?
The current quarterly long term liabilities of LYEL is $55.01 M
What is the all time high quarterly long term liabilities for Lyell Immunopharma?
Lyell Immunopharma all-time high quarterly total long term liabilities is $152.58 M
What is Lyell Immunopharma quarterly long term liabilities year-on-year change?
Over the past year, LYEL quarterly total long term liabilities has changed by -$7.35 M (-11.78%)